Skip to content
Back to Blog
Government Programs
2026-03-177 min read52

2026 Non-Capital Region SME R&D Incentive System: Complete Analysis and Strategy

A comprehensive guide to the 2-point incentive system for non-capital region companies in 2026 government R&D support programs.

KITIM 컨설팅팀

What is the 2026 Non-Capital Region R&D Incentive System?

According to the 2026 SME Technology Development Support Program announcement, the government has set a target to allocate more than 50% of new project budgets to regional companies across five major programs. Additionally, a 2-point bonus is universally applied to all non-capital region companies.

This reflects the government's strong commitment to expanding R&D support beyond the Seoul metropolitan area, creating significant opportunities for SMEs located in regional areas.

Eligible Programs

  • SME Technology Innovation Development: Up to KRW 300 million, within 2 years
  • Public-Private Joint Technology Commercialization: Matching private investment, up to KRW 500 million
  • Investment-Linked Technology Development: R&D support linked with investment
  • Startup Growth Technology Development: For early-stage startups
  • Scale-up TIPS: For growth-stage companies (expanded in 2026)
  • All programs grant non-capital region companies a 2-point evaluation bonus, which can make a decisive difference in project selection where scores typically compete in the 80-90 point range.

    Effective Utilization Strategies

    1. Verify Headquarters Location

    The bonus is based on the headquarters address on business registration. Companies with headquarters in the capital region but factories in other regions do not qualify. If substantial business activities occur outside the capital region, consider relocating headquarters.

    2. Select Region-Specific R&D Topics

    Choosing R&D topics connected to regional industrial ecosystems enables simultaneous application to region-specific programs beyond just the bonus points. For example, linking with Daegu's medical devices, Gwangju's photonics, or Chungbuk's bio industries creates synergies.

    3. Build Consortiums with Regional Research Institutions

    Establishing joint research frameworks with regional universities and research institutions can supplement research capability scores in evaluations. Collaboration with regional branches of government-funded research institutes like KIST and KAIST is also effective.

    4. Apply to Multiple Programs Simultaneously

    Leveraging the 2-point advantage, a strategy of applying to 2-3 programs simultaneously is viable. However, duplicate applications for the same technology are grounds for exclusion, so clearly distinguish technical scopes.

    Important Notes

  • Bonuses are applied during document evaluation, with no separate bonus for presentation evaluations
  • Non-capital region status is determined as of the announcement date, so planned relocations should be completed beforehand
  • The new 50% regional allocation target in 2026 strengthens the overall preference for regional companies beyond just bonus points
  • Contact KITIM

    KITIM supports the entire process from R&D project planning to application and evaluation preparation for regional companies. For expert consulting on regional R&D strategy development and improving project selection rates, please contact us through [KITIM Contact](/contact).

    Non-Capital RegionR&D IncentiveGovernment SupportSMERegional Balance

    Related Posts

    Bio

    Biologics Approval Fees Rise From KRW 8.03M to 20.71M, Data-Submission Drugs About 6x — MFDS Fee Regulation Amendment Pre-Announced Nov 6, 2026 (Comments Due Nov 26 / Dec 16): Filing Timing, Budget Review and Fee-Reduction Checks for Pharma & Bio SMEs

    Under the fee amendment MFDS proposed on November 6, approval fees for new biologics would rise from KRW 8.03 million to KRW 20.71 million, and fees for data-submission drugs would go up about sixfold. This guide shows pharma and bio SMEs how to review their filing timing, budgets, fee-reduction eligibility and public comments.

    2026-11-09
    Management Consulting

    Factories With 20–49 Workers Will Need a Safety or Health Manager — Korea's First Tripartite Agreement on November 5 (About 30,000 Sites in 5 Industries Including Manufacturing, Decree Amendment in 2027, Target Start 2028), the Owner-Led Alternative and Government Payroll Support: A Preparation Guide for Small Manufacturers

    Under Korea's November 5 tripartite agreement, about 30,000 sites with 20–49 workers in manufacturing and four other industries are expected to need a qualified safety or health manager from 2028. This guide covers what is settled and what is still open, the owner-led alternative, a cost comparison, and a preparation checklist.

    2026-11-09
    Government Programs

    SMEs Can Now Enter the KRW 1,500 Trillion 'Mega Project' Supply Chain from the Design Stage — MSS Joins as a Lead Ministry, Large/Mid-Tier–SME Councils and Regional Councils Launch (Nov 6 Plan to Expand Planning-Stage Participation), and How SMEs Targeting Semiconductor, AI Data Center and Physical AI Supply Chains Should Prepare Validation, Certification and Mass-Production Qualification

    MSS has joined Korea's KRW 1,500 trillion mega projects as a lead ministry and plans to bring SMEs in from the planning stage. This guide covers how the central and regional councils will work and how to line up support programs against the validation, certification and mass-production barriers.

    2026-11-09
    Updated daily

    Let AI find government support programs in this field

    Complete a 3-minute company assessment and we will recommend programs that fit your company, each with a match score. It is free.

    Get AI-Matched Programs for Free

    Need Consulting?

    Our technology innovation consultants will propose the optimal solution for your company.